Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Stereotaxis

Stereotaxis
1990 FOUNDED
PUBLIC STATUS
101-200 EMPLOYEES
STXS STOCK SYMBOL
$3.48 SHARE PRICE (As of Friday Closing)
Description

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. Over 100 issued patents support the company platform. The core components of its systems have received regulatory clearance including United States, European Union, Japan, Canada, and China.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Medical Supplies
Stock Exchange
ASE
Primary Office
  • 4320 Forest Park Avenue
  • Suite 100
  • Saint Louis, MO 63108
  • United States

+1 (314) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Stereotaxis’s full profile, request a free trial.

Stereotaxis Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$1.00 - $4.75 $207M $3.55 -$0.10 131K 59.4M

Stereotaxis Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 174,539 58,226 40,530 11,128
Revenue 28,632 29,347 31,144 32,164
EBITDA (3,979) 712 (4,954) (2,236)
Net Income (4,237) 117 (5,887) (5,287)
Total Assets 21,255 18,515 10,667 20,966
Total Debt 5,272 0 19,575 19,787
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Stereotaxis Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Stereotaxis‘s full profile, request access.

Request full access to PitchBook

Stereotaxis Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is reserved for PitchBook Platform users. To explore Stereotaxis‘s full profile, request access.

Request full access to PitchBook
To view this company’s complete Cap Table, request access »

Stereotaxis Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Hansen Medical Formerly VC-backed Mountain View, CA 000 00000 000000&0 00000
0. 00000 000000000 Corporation Melsungen, Germany 00000
00000000 00000000 Formerly VC-backed Waltham, MA 000 00000 000000&0 00000
00000 0000000 Corporate Backed or Acquired Toronto, Canada 0 000.00 000000000 000.00
00000000 Venture Capital-Backed Sunnyvale, CA 00 00000 00000000000 00000
To view this company’s complete list of competitors, request access »

Stereotaxis Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Stereotaxis‘s full profile, request access.

Request full access to PitchBook

Stereotaxis Executive Team (8)

Name Title Board
Seat
Contact
Info
David Fischel Chief Executive Officer & Chairman
Kevin Barry Secretary & Chief Compliance Officer

6 Former Executives

You’re viewing 2 of 8 executives. Get the full list »

Stereotaxis Board Members (13)

Name Representing Role Since Contact
Info
Arun Menawat Ph.D Self Board Member 000 0000
David Benfer Self Board Member 000 0000
David Fischel Stereotaxis Chief Executive Officer & Chairman 000 0000
Robert Messey Self Board Member 000 0000

9 Former Board Members

You’re viewing 4 of 13 board members. Get the full list »